This site is intended for healthcare professionals

Go to /sign-in page

You can view 5 more pages before signing in

Go to /pro/cpd-dashboard page

This page is worth 0.05 CPD credits. CPD dashboard

Go to /account/subscription-details page

This page is worth 0.05 CPD credits. Upgrade to Pro

Pigment dispersion syndrome (PDS)

Authoring team

Pigment dispersion syndrome (PDS)

  • can lead to secondary open angle glaucoma
  • is primarily a disease of young people, myopes and men
  • characterized by the presence of Krukenberg spindles, iris trans-illumination defects, trabecular meshwork pigmentation and backward bowing of the iris (1)
    • the classic diagnostic triad consists of corneal endothelial pigmentation (Krukenberg spindle), radial mid-peripheral iris transillumination,anddensetrabecularpigmentation (2)
    • posterior bowing of the iris causes rubbing of the pigmented iris epithelium against lens structures, liberation of pigment and trabecular meshwork changes that result in reduced aqueous outflow with the risk of glaucoma
    • peripheral laser iridotomy can reverse backward bowing of the iris and may prevent progression of pigmentary glaucoma.

Reference:

  • Niyadurupola N, Broadway DC. Pigment dispersion syndrome and pigmentary glaucoma-a major review. Clinical & Experimental Ophthalmology. 2008 Dec;36(9):868-882. DOI: 10.1111/j.1442-9071.2009.01920.x. PMID: 19278484.
  • Fine BS, Yanoff M, Sheie HG. Pigmentary "glaucoma":A histologic study. Trans Am Acad Ophthalmol Otolaryngol. 1974;7:314-25

Create an account to add page annotations

Annotations allow you to add information to this page that would be handy to have on hand during a consultation. E.g. a website or number. This information will always show when you visit this page.

The content herein is provided for informational purposes and does not replace the need to apply professional clinical judgement when diagnosing or treating any medical condition. A licensed medical practitioner should be consulted for diagnosis and treatment of any and all medical conditions.

Connect

Copyright 2024 Oxbridge Solutions Limited, a subsidiary of OmniaMed Communications Limited. All rights reserved. Any distribution or duplication of the information contained herein is strictly prohibited. Oxbridge Solutions receives funding from advertising but maintains editorial independence.